This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Takara Bio's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was 円395.878. Takara Bio's 10-Year median PS Ratio is 6.5178. Therefore, the Median PS Value for today is 円2,580.25.
As of today (2024-05-22), Takara Bio's share price is 円1092.00. Takara Bio's Median PS Value is 円2,580.25. Therefore, Takara Bio's Price to Median PS Value for today is 0.42.
The historical rank and industry rank for Takara Bio's Median PS Value or its related term are showing as below:
TSE:4974'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.36 Med: 1.13 Max: 1.8
Current: 0.42
During the past 13 years, the highest Price to Median PS Value of Takara Bio was 1.80. The lowest was 0.36. And the median was 1.13.
TSE:4974's Price-to-Median-PS-Value is ranked better than 72.52% of 262
companies
in the Biotechnology industry
Industry Median: 0.695
vs TSE:4974: 0.42
Takara Bio Median PS Value Historical Data
The historical data trend for Takara Bio's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Takara Bio's Median PS Value
For the Biotechnology subindustry, Takara Bio's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Takara Bio's Price-to-Median-PS-Value Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Takara Bio's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Takara Bio's Price-to-Median-PS-Value falls into.
Takara Bio Median PS Value Calculation
Takara Bio's Median PS Value for today is calculated as
10-Year Median PS Ratio is 6.5178.
Takara Bio's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円395.878.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Takara Bio (TSE:4974) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Takara Bio's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
1092.00
/
2,580.25
=
0.42
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Takara Bio Median PS Value Related Terms
Thank you for viewing the detailed overview of Takara Bio's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Takara Bio Inc is a biotechnology company that develops gene therapy procedures. The company reports in three business segments: Bioindustry, Gene therapy, and AgriBio. Takara's bioindustry business provides research reagents, scientific instruments, and various contracted services to universities and companies around the world. The company's gene therapy business is focused on treating cancer and HIV. Its AgriBio business aims to leverage biotechnologies in the food ingredient field, including large-scale mushroom production. The vast majority of Takara's revenue is derived from its bioindustry segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:4974 has been successfully added to your 